Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451

被引:10
作者
Firouzian, Azadeh [1 ]
Whittington, Alex [2 ]
Searle, Graham E. [1 ]
Koychev, Ivan [3 ]
Zamboni, Giovanna [4 ]
Lovestone, Simon [3 ]
Gunn, Roger N. [1 ,2 ,5 ]
机构
[1] Imperial Coll London, Hammersmith Hosp, Imanova Ltd, Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England
[2] Imperial Coll London, Dept Med, Fac Med, South Kensington Campus, London SW7 2AZ, England
[3] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
[4] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
[5] Univ Oxford, Dept Engn Sci, Oxford, England
来源
EJNMMI RESEARCH | 2018年 / 8卷
基金
英国医学研究理事会;
关键词
Alzheimer's disease; PET; Amyloid; Tau; Modelling; POSITRON-EMISSION-TOMOGRAPHY; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; NEUROFIBRILLARY PATHOLOGY; PET RADIOTRACER; F-18-AV-1451; RECOMMENDATIONS; BINDING; TRACER;
D O I
10.1186/s13550-018-0371-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, A beta plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [F-18]AV45 and [F-18]AV1451 to image A beta and tau, respectively, in subjects with AD. Fifteen subjects with early stage AD underwent a T1-weighted structural MRI and two dynamic PET scans to image A beta (60 min, [F-18]AV45) and tau (120 min, [F-18]AV1451). Both dynamic BPND and static SUVR outcome measures were calculated and compared for 12 out of 15 subjects who completed 60 min of the A beta PET scan and at least 110 min of the tau PET scan. The SRTM and reference Logan graphical analysis were applied to the dynamic data to estimate regional BPND values and SUVR ratios from the static data. Optimal acquisition windows were explored for both the dynamic and static acquisitions. In addition, the spatial correlation between regional A beta and tau signals was explored. Results: Both the SRTM and graphical analysis methods showed a good fit to the dynamic data for both A beta and tau dynamic PET scans. Mean regional BPND estimates became stable 30 min p.i. for [F-18]AV45 and 80 min p.i. for [F-18]AV1451. Time stability analysis of static SUVR data showed that the outcome measure starts to become stable for scan windows of 30-50 min p.i. for [F-18]AV45 and 80-100 min p.i. for [F-18]AV1451. The results from these time windows correlated well with the results from the full dynamic analysis for both tracers (R-2 = 0.74 for [F-18]AV45 and R-2 = 0.88 for [F-18]AV1451). There was a high correlation between amyloid uptake estimate using both dynamic analysis methods in thalamus and tau uptake in thalamus, hippocampus and amygdala. Conclusions: Short static PET scans at appropriate time windows provided SUVR values which were in reasonable agreement with BPND values calculated from dynamic scans using SRTM and reference Logan. These simplified methods may be appropriate for classification and intervention studies, although caution should be employed when considering interventional studies where blood flow and extraction could change.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer's disease
    Quattrini, Giulia
    Ferrari, Clarissa
    Pievani, Michela
    Geviti, Andrea
    Ribaldi, Federica
    Scheffler, Max
    Frisoni, Giovanni B.
    Garibotto, Valentina
    Marizzoni, Moira
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3265 - 3275
  • [32] [18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window
    Lagarde, Julien
    Olivieri, Pauline
    Caille, Fabien
    Gervais, Philippe
    Baron, Jean-Claude
    Bottlaender, Michel
    Sarazin, Marie
    JOURNAL OF NEUROLOGY, 2019, 266 (12) : 3087 - 3097
  • [33] 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
    Mattsson, Niklas
    Scholl, Michael
    Strandberg, Olof
    Smith, Ruben
    Palmqvist, Sebastian
    Insel, Philip S.
    Hgerstrom, Douglas
    Ohlsson, Tomas
    Zetterberg, Henrik
    Jogi, Jonas
    Blennow, Kaj
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2017, 9 (09) : 1212 - 1223
  • [34] Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease
    Liu, Yajing
    Zhu, Lin
    Ploessl, Karl
    Choi, Seok Rye
    Qiao, Hongwen
    Sun, Xiaotao
    Li, Song
    Zha, Zhihao
    Kung, Hank F.
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (08) : 917 - 925
  • [35] Preparation and stability of ethanol-free solution of [18F]florbetapir ([18F]AV-45) for positron emission tomography amyloid imaging
    Hayashi, Kazutaka
    Tachibana, Akiko
    Tazawa, Shusaku
    Mizukawa, Yosuke
    Osaki, Katsuhiko
    Morimoto, Yoko
    Zochi, Riyo
    Kurahashi, Masahiro
    Aki, Hatsumi
    Takahashi, Kazuhiro
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (05) : 295 - 300
  • [36] Potential Utility of the Tau Deposit Tracer [18F]T807 (aka [18F]AV-1451) as a PET Biomarker for Neurodegeneration in Clinical Trials
    Mintun, Mark
    Devous, Michael, Sr.
    Attardo, Giorgio
    Joshi, Abhinay
    Schwarz, Adam
    Shcherbinin, Sergey
    Siderowf, Andrew
    Lin, Yin Guo
    Liang, Qianwa
    Conway, Kelly
    Gomez, Felipe
    Pontecorvo, Michael
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S207 - S208
  • [37] [18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series
    Marquie, Marta
    Aguero, Cinthya
    Amaral, Ana C.
    Villarejo-Galende, Alberto
    Ramanan, Prianca
    Chong, Michael Siao Tick
    Saez-Calveras, Nil
    Bennett, Rachel E.
    Verwer, Eline E.
    Kim, Sally Ji Who
    Dhaynaut, Maeva
    Alvarez, Victor E.
    Johnson, Keith A.
    McKee, Ann C.
    Frosch, Matthew P.
    Gomez-Isla, Teresa
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [38] MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy
    Whitwell, Jennifer L.
    Tosakulwong, Nirubol
    Schwarz, Christopher G.
    Botha, Hugo
    Senjem, Matthew L.
    Spychalla, Anthony J.
    Ahlskog, J. Eric
    Knopman, David S.
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Josephs, Keith A.
    MOVEMENT DISORDERS, 2019, 34 (01) : 105 - 113
  • [39] Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
    Mattsson, Niklas
    Insel, Philip S.
    Donohue, Michael
    Jogi, Jonas
    Ossenkoppele, Rik
    Olsson, Tomas
    Scholl, Michael
    Smith, Ruben
    Hansson, Oskar
    ALZHEIMERS & DEMENTIA, 2019, 15 (04) : 570 - 580
  • [40] A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain
    Xiao, Hao
    Choi, Seok Rye
    Zhao, Ruiyue
    Ploessl, Karl
    Alexoff, David
    Zhu, Lin
    Zha, Zhihao
    Kung, Hank F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (07): : 1086 - 1092